Yoon Byung-Ho, Ko Young Seung, Jang Suk-Hwan, Ha Jeong Ku
Department of Orthopaedic Surgery, Inje University College of Medicine, Seoul Paik Hospital, Seoul, Korea.
J Orthop Trauma. 2017 Aug;31(8):414-419. doi: 10.1097/BOT.0000000000000870.
To determine whether hip fracture surgery (HFS) without transfusion affects postoperative mortality and complications in elderly patients.
Retrospective comparative study.
Three hundred fourteen patients ≥65 years of age who underwent HFS between May 2003 and December 2014. Patients were divided into 2 groups: those who consented to blood transfusion if needed and those who did not. One-to-one propensity score matching generated 50 matched pairs of patients.
Patients underwent HFS with or without blood transfusion. In the no transfusion group, simultaneous administration of erythropoietin and iron was used as an alternative.
The primary outcome was postoperative mortality (90-day, 1-year, overall). The secondary outcomes were hemoglobin change and the incidence of postoperative complications.
HFS using a no transfusion protocol was not associated with increased mortality at any time point. Mean hemoglobin levels were significantly different between the 2 groups on postoperative day 1 (11.0 ± 1.3 vs. 10.5 ± 1.6, P = 0.002) but levels completely recovered within 2 weeks in both groups. There was also no difference in postoperative complication rates between the 2 groups, and overall hospital stays and charges were similar.
An HFS protocol without blood transfusion was not associated with increased mortality or complications in elderly patients.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
确定不输血的髋部骨折手术(HFS)是否会影响老年患者的术后死亡率和并发症。
回顾性比较研究。
2003年5月至2014年12月期间接受HFS的314例年龄≥65岁的患者。患者分为两组:一组为必要时同意输血的患者,另一组为不同意输血的患者。通过一对一倾向评分匹配产生50对匹配患者。
患者接受有或无输血的HFS。在不输血组中,同时给予促红细胞生成素和铁剂作为替代方案。
主要结局为术后死亡率(90天、1年、总体)。次要结局为血红蛋白变化和术后并发症发生率。
采用不输血方案的HFS在任何时间点均与死亡率增加无关。术后第1天两组的平均血红蛋白水平有显著差异(11.0±1.3 vs. 10.5±1.6,P = 0.002),但两组均在2周内完全恢复。两组术后并发症发生率也无差异,总体住院时间和费用相似。
不输血的HFS方案与老年患者死亡率或并发症增加无关。
治疗性III级。有关证据水平的完整描述,请参阅作者指南。